UnknownNot applicableNCT01990092

The Nutritional Benefits of Metanx in Patients With Diabetic Peripheral Neuropathy (MEDIAN)

Studying OBSOLETE: Acquired metabolic neuropathy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Pamlab, Inc.
Principal Investigator
Roy Freeman, MD
Beth Israel Deaconess Medical Center
Intervention
Metanx(other)
Enrollment
238 target
Eligibility
25-80 years · All sexes
Timeline
20132018

Study locations (25)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01990092 on ClinicalTrials.gov

Other trials for OBSOLETE: Acquired metabolic neuropathy

Additional recruiting or active studies for the same condition.

See all trials for OBSOLETE: Acquired metabolic neuropathy

← Back to all trials